<DOC>
	<DOCNO>NCT01892709</DOCNO>
	<brief_summary>This exploratory , hypothesis-generating safety efficacy study patient come ER acute ( le 7 day duration ) severe pain . Patients chronic pain enrol . Eligible patient receive maximum 4 mg IV hydromorphone 4 hour period . Hydromorphone give 1 mg increment base patient responds question , `` Do want pain medicine ? '' . This question ask repeatedly 30 minute patient answer `` '' 30 minute recent dose IV hydromorphone ( occurs patient answer `` yes '' ) . Up 10 % ( approximately 30 patient ) serve pilot start study .</brief_summary>
	<brief_title>Titration Intravenous Hydromorphone</brief_title>
	<detailed_description />
	<mesh_term>Hydromorphone</mesh_term>
	<criteria>1 . Age great 21 year : Patients age 21 automatically triaged Children 's Hospital Montefiore Emergency Department , hence enrol study . 2 . Age le 65 year : Patients age 65 exclude study effect opioids elderly may different nonelderly . 3 . Pain onset within 7 day : Pain within seven day definition acute pain use ED literature . 4 . ED attend physician 's judgment patient 's pain warrant use morphine 5 . Normal mental status : In order provide measure pain experienced patient need normal mental status . Orientation person , place time use indicator sufficiently normal mental status participate study . 1 . Prior use methadone : effect methadone use perception acute pain unknown suspect alter . Similar sickle cell patient chronic cancer patient , patient methadone usually require significantly high dos opioids control pain . 2 . Use opioids tramadol within past 24 hour : avoid introduce bias relate opioid tolerance may alter response study medication thereby mask medication 's effect . 3 . Prior adverse reaction hydromorphone : patient exclude state allergy hydromorphone . 4 . Chronic pain syndrome : frequently recurrent daily pain least 3 month result alteration pain perception think due downregulation pain receptor . Examples chronic pain syndrome include sickle cell anemia , osteoarthritis , fibromyalgia , migraine , peripheral neuropathy . 5 . Patients attend physician suspect addict opioids : patient exclude attend suspect patient may addict opioids seek obtain diversionary reason , monetary profit illicit use . 6 . Alcohol intoxication : presence alcohol intoxication judge treat physician may alter perception , report , treatment pain . 7 . SBP &lt; 100 mm Hg : Hydromorphone produce peripheral vasodilation may result orthostatic hypotension syncope . 8 . Respiratory rate &lt; 12/minute : Hydromorphone cause respiratory depression . 9 . Oxygen saturation &lt; 95 % room air : For study , oxygen saturation must 95 % room air order enrol . 10 . Heart rate &lt; 60 beats/minute : Hydromorphone cause bradycardia . 11 . Use MAO inhibitor past 30 day : MAOs report intensify effect least one opioid drug cause anxiety , confusion significant respiratory depression coma . 12 . C02 measurement great 46 : three subset patient CO2 measure use handheld capnometer prior enrollment study . If CO2 measurement great 46 , patient exclude study . The 3 subset follow : 1 . All patient history COPD 2 . All patient report history asthma together great 20 packyear smoke history 3 . All patient report less 20 packyear smoke history asthma exacerbation</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>acute</keyword>
	<keyword>pain</keyword>
	<keyword>emergency department</keyword>
	<keyword>hydromorphone</keyword>
	<keyword>ER</keyword>
</DOC>